These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9698701)

  • 1. Montelukast for persistent asthma.
    Med Lett Drugs Ther; 1998 Jul; 40(1031):71-3. PubMed ID: 9698701
    [No Abstract]   [Full Text] [Related]  

  • 2. [Montelukast].
    Münzel F; Mühlhäuser U; Eschenhagen T
    Dtsch Med Wochenschr; 2002 Nov; 127(44):2337-9. PubMed ID: 12410440
    [No Abstract]   [Full Text] [Related]  

  • 3. Leukotriene receptor antagonists versus inhaled steroids in asthma.
    Richardson CR
    J Fam Pract; 1999 Jul; 48(7):495-6. PubMed ID: 10428241
    [No Abstract]   [Full Text] [Related]  

  • 4. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
    Wahn U; Dass SB
    Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montelukast in childhood asthma.
    Mehta PN
    Indian Pediatr; 2000 Nov; 37(11):1201-9. PubMed ID: 11086302
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy.
    Maspero JF; Dueñas-Meza E; Volovitz B; Pinacho Daza C; Kosa L; Vrijens F; Leff JA
    Curr Med Res Opin; 2001; 17(2):96-104. PubMed ID: 11759189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Montelukast for mild and exercise-induced asthma.
    Adelman A
    J Fam Pract; 1998 Nov; 47(5):335. PubMed ID: 9834763
    [No Abstract]   [Full Text] [Related]  

  • 8. Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study.
    Simons FE; Villa JR; Lee BW; Teper AM; Lyttle B; Aristizabal G; Laessig W; Schuster A; Perez-Frias J; Sekerel BE; Menten J; Leff JA
    J Pediatr; 2001 May; 138(5):694-8. PubMed ID: 11343045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
    Grosclaude M; Cerruti JL; Delannay B; Hérent M; Spilthooren F; Desfougères JL
    Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):356-62. PubMed ID: 14716965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing risk: Data from montelukast clinical trials.
    Kelsay K
    J Allergy Clin Immunol; 2009 Oct; 124(4):697-8. PubMed ID: 19815115
    [No Abstract]   [Full Text] [Related]  

  • 11. Extrapolating evidence beyond age groups.
    Bisgaard H; Bønnelykke K
    J Allergy Clin Immunol; 2008 Apr; 121(4):1066-7; author reply 1067-8. PubMed ID: 18325574
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
    Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
    J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of montelukast, budesonide alone, and in combination on exercise-induced bronchoconstriction.
    Duong M; Amin R; Baatjes AJ; Kritzinger F; Qi Y; Meghji Z; Lou W; Grasemann H; O'Byrne PM; Subbarao P
    J Allergy Clin Immunol; 2012 Aug; 130(2):535-9.e3. PubMed ID: 22534533
    [No Abstract]   [Full Text] [Related]  

  • 15. [Airway diseases--leukotriene antagonist kills two flies with one fly-flap].
    MMW Fortschr Med; 2006 Mar; 148(11):66-7. PubMed ID: 16612967
    [No Abstract]   [Full Text] [Related]  

  • 16. [Importance of leukotriene antagonists in asthma therapy raised].
    MMW Fortschr Med; 2008 Mar; 150(13):44-5. PubMed ID: 18522358
    [No Abstract]   [Full Text] [Related]  

  • 17. Reports of suicidality in clinical trials of montelukast.
    Philip G; Hustad C; Noonan G; Malice MP; Ezekowitz A; Reiss TF; Knorr B
    J Allergy Clin Immunol; 2009 Oct; 124(4):691-6.e6. PubMed ID: 19815114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
    Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
    J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Montelukast and Churg-Strauss syndrome.
    Hosker HS; Tuggey JM
    Thorax; 2001 Mar; 56(3):244. PubMed ID: 11245146
    [No Abstract]   [Full Text] [Related]  

  • 20. The targeted oral, once-daily phosphodiesterase 4 inhibitor roflumilast and the leukotriene receptor antagonist montelukast do not exhibit significant pharmacokinetic interactions.
    Böhmer GM; Nassr N; Wenger M; Hünnemeyer A; Lahu G; Templin S; Gleiter CH; Hermann R
    J Clin Pharmacol; 2009 Apr; 49(4):389-97. PubMed ID: 19318692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.